Memed

1 known investors

MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers. The test serves physicians and hospitals to reduce inappropriate antibiotic prescriptions and improve patient outcomes in acute infection management.